Standout Papers

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-... 2014 2026 2018 2022 395
  1. Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2 (2014)
    Martine Piccart, Gabriel N. Hortobágyi et al. Annals of Oncology

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 60 standout
Sub-graph 1 of 21

Citing Papers

The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology
2024 Standout
Fluorescent Probes for Disease Diagnosis
2024 Standout
5 intermediate papers

Works of Ines Deleu being referenced

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2
2014 Standout
Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial
2011
and 2 more

Author Peers

Author Last Decade Papers Cites
Ines Deleu 681 499 135 339 15 933
Susan S. Padalecki 712 273 59 597 17 1.2k
Akeila Bellahcène 531 172 79 528 22 1.1k
JuanJuan Yin 712 223 37 599 9 1.1k
Xiang Peng 444 173 51 580 22 952
R. Goerner 739 219 62 147 8 871
Marco A. Di Grappa 603 173 235 559 14 1.0k
Gina Chia‐Yi Chu 433 367 37 529 23 1.0k
Yoo‐Joung Ko 217 603 202 256 21 870
S Katsuda 213 227 63 158 21 914
S. Ashley 759 129 327 227 12 1.1k

All Works

Loading papers...

Rankless by CCL
2026